Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025 
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient 
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
The Korea Photonics Technology Institute has developed a free-space augmented reality (AR) system that allows examination of breast cancer tissue’s location and shape through the naked eye.
The system, developed in collaboration with the institution, local AR developer Apros Corp., and the National Cancer Center, uses a small light projection device to broadcast a video of breast cancer captured by a camera onto the afflicted region for surgeons.
The near-infrared fluorescence probe video system that is typically used for breast cancer surgery does not allow surgeons to see the wavelength of the light generated by the fluorescent contrast agent with their naked eyes, necessitating the use of a separate monitor with a dedicated camera for the surgery.
The innovative method reflects real-time changes in the position of breast cancer cells caused by human tissue flexibility, and shows the video immediately on the affected area to aid the surgeon's attention, reducing the time spent on the surgery.
The new technology has passed performance tests utilizing National Cancer Center-created breast cancer models and animal testing, with medical certification and clinical trials scheduled for the near future.
